Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Alembic Group Stocks

1 Yr CAGR -11.44%

3 Yr CAGR -1.15%

Total Companies 3

List of Alembic Stocks as on 13-Oct-2026

Filter

	Company Name	DeciZen	CMP	Price Change	Market Cap (Cr)	52 Week High	52 Week Low	ROE	P/E Ratio	P / BV	EV/ EBITDA
1	Alembic Pharma	4 Q V+ PT	788	-1.67%	15,746 Small Cap	998 04 Nov, 25	635 23 Mar, 26	12.64	22.71	2.69	13.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Paushak	4 Q V PT	725	3.53%	1,727 Small Cap	827 03 Sep, 26	343 30 Mar, 26	0.00	-	0.00	-	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Alembic	4 Q V PT	99.35	-0.05%	2,552 Small Cap	118 03 Sep, 26	70.64 30 Mar, 26	13.14	7.96	1.04	15.83	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

Top Business Houses

Tata

26 Companies

Market Cap: ₹ 24,42,801 Cr.

1 Yr CAGR -10.14%

3 Yr CAGR 1.12%

Mukesh Ambani

8 Companies

Market Cap: ₹ 17,39,552 Cr.

1 Yr CAGR -22.11%

3 Yr CAGR -5.68%

Adani

7 Companies

Market Cap: ₹ 15,73,480 Cr.

1 Yr CAGR 16.13%

3 Yr CAGR 9.26%

Bajaj

12 Companies

Market Cap: ₹ 13,65,554 Cr.

1 Yr CAGR -13.02%

3 Yr CAGR 15.20%

HDFC

4 Companies

Market Cap: ₹ 13,56,709 Cr.

1 Yr CAGR -13.79%

3 Yr CAGR 2.61%

Bharti

3 Companies

Market Cap: ₹ 13,03,862 Cr.

1 Yr CAGR -9.18%

3 Yr CAGR 23.31%

ICICI

4 Companies

Market Cap: ₹ 12,72,970 Cr.

1 Yr CAGR 0.05%

3 Yr CAGR 6.68%

PSU - SBI

4 Companies

Market Cap: ₹ 12,08,309 Cr.

1 Yr CAGR -12.05%

3 Yr CAGR 3.88%

News about Alembic Stocks in India

Oct, 2026

Alembic informs about newspaper advertisement

Alembic has informed that it enclosed paper cuttings of newspaper advertisement issued regarding another special window opened for transfer and dematerialization of physical securities pursuant to SEBI Circular No. H0/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated 30th January, 2026, published in Indian Express (English Edition) and Financial Express (Gujarati Edition - vernacular language) on 8th October, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Alembic Pharmaceuticals informs about certificate

Alembic Pharmaceuticals has informed that it enclosed a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2026 received from MUFG lntime India (Formerly known as Link lntime India), Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Alembic Pharmaceuticals informs about disclosure

Alembic Pharmaceuticals has informed that the company has successfully completed an unannounced onsite Bioequivalence inspection conducted by United States Food and Drug Administration (‘USFDA’) at the Company’s Bioequivalence Facility located in Vadodara, Gujarat, with no Form 483 observations. The unannounced onsite USFDA Bioequivalence inspection was conducted from 31st August, 2026 to 10th September, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

USFDA completes inspection at Alembic Pharmaceuticals’ Bioequivalence Facility in Vadodara

The inspection was conducted at the company’s Bioequivalence Facility located in Vadodara and concluded with no Form 483 observations

Sep, 2026

Alembic Pharmaceuticals incorporates subsidiary in Dubai

The new entity has been incorporated to explore new business opportunities and to promote, sale and distribute pharmaceutical product(s) of the company

Aug, 2026

Alembic informs about newspaper cuttings

Alembic has informed that it enclosed newspaper cuttings related to advertisement published for Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2026, in Indian Express (English Edition) and Financial Express (Gujarati Edition- vernacular language) on 12th August, 2026. The said newspaper advertisement provides a Quick Response (QR) Code and the weblink of the Company's website to access complete financial results for the said period. The said newspaper cuttings are also available on the website of the Company at Investors Section.

The above information is a part of company’s filings submitted to BSE.

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

You have 98 views remaining as a Guest User. Login | Register Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

^ Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Alembic Group Stocks

Top Business Houses

Tata

Mukesh Ambani

Adani

Bajaj

HDFC

Bharti

ICICI

PSU - SBI

News about Alembic Stocks in India

Alembic informs about newspaper advertisement

Alembic Pharmaceuticals informs about certificate

Alembic Pharmaceuticals informs about disclosure

USFDA completes inspection at Alembic Pharmaceuticals’ Bioequivalence Facility in Vadodara

Alembic Pharmaceuticals incorporates subsidiary in Dubai

Alembic informs about newspaper cuttings

Track Now:

Trending Blogs